There has been widespread success in treating blood cancers, while progress in solid tumors has been more limited.

B&B Manufacturing re-arranges machines into cells, some of which can be dedicated to one customer’s parts. While B&B Manufacturing Co. Inc discribes itself as a job shop, it seems to have the level of ...

Cellular Origins, a TTP company, acquired the ACTIA (Autologous Cell Therapy Industrial Automation) Platform IP, developed by Geoff Hodge while CEO of SOTIO Biotech US. The ACTIA Platform complements ...

A study led by the School of Engineering of the Hong Kong University of Science and Technology (HKUST) has developed an innovative method that overcomes the limitations of traditional additive ...